Open AccessACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs
Author(s) -
Keene Bruce W.,
Atkins Clarke E.,
Bonagura John D.,
Fox Philip R.,
Häggström Jens,
Fuentes Virginia Luis,
Oyama Mark A.,
Rush John E.,
Stepien Rebecca,
Uechi Masami
Publication year - 2019
Publication title -
journal of veterinary internal medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.356
H-Index - 103
eISSN - 1939-1676
pISSN - 0891-6640
DOI - 10.1111/jvim.15488
Subject(s) - medicine , heart failure , mitral valve , disease , intensive care medicine , valvular heart disease , pulmonary hypertension , medical therapy , cardiology
This report, issued by the ACVIM Specialty of Cardiology consensus panel, revises guidelines for the diagnosis and treatment of myxomatous mitral valve disease (MMVD, also known as endocardiosis and degenerative or chronic valvular heart disease) in dogs, originally published in 2009. Updates were made to diagnostic, as well as medical, surgical, and dietary treatment recommendations. The strength of these recommendations was based on both the quantity and quality of available evidence supporting diagnostic and therapeutic decisions. Management of MMVD before the onset of clinical signs of heart failure has changed substantially compared with the 2009 guidelines, and new strategies to diagnose and treat advanced heart failure and pulmonary hypertension are reviewed.